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Elevated Plasma HsCRP Level Is a Predictor of Periprocedural Myocardial
Injury During PCI
Mohsin Ahmed, Nazir Ahammed Chowdhury, Afzalur Rahman, Mostaﬁzur Rahman
National Institute of Cardiovascular Disease, Dhaka, Bangladesh
Background: Elevated high sensitivity C-reactive protein (hs-CRP) has been well
known as a biomarker reﬂecting inﬂammatory process for prediction of ischemic
events among patients with coronary artery disease. Relatively small studies have
identiﬁed a heightened and sustained inﬂammatory response after PCI to be a pre-
dictor of periprocedural events after coronary angioplasty and a marker of increased
restenosis risk among patients undergoing coronary stenting. Embolization of
atherosclerotic and thrombotic debris can induce myocardial necrosis during percu-
taneous coronary interventions (PCIs). This study was designed to evaluate whether
pre procedural hs-CRP level is associated with procedure related distal micro-
embolization producing myocardial injury (assessed by CK-MB level) after percuta-
neous coronary intervention (PCI).
Methods: A total of 310 patients with chronic stable angina and acute coronary
syndrome, who would undergo elective percutaneous coronary intervention were
evaluated in National Institute of Cardiovascular Disease (NICVD), Dhaka with a
view to evaluate the relationship between preprocedural hs-CRP and rise of CK-MB
level, before and after PCI. Patients were divided in 2 groups according to hs-CRP:
Group I ¼ hs-CRP < 3 mg/ L, Group II ¼ hs-CRP > 3 mg/ L.
Results: A total of 310 who were divided into two groups: Normal CRP group (n ¼
131) and elevated CRP group (n¼ 179). Following PCI, CK-MB level was raised
from baseline in both groups. In normal CRP group, there was no signiﬁcant elevation
of CK-MB level after PCI (Pre-procedural VS Post-procedural: 18.6  5.4 VS 29.1 
5.6 mg/L, p¼ ns). In elevated CRP group, there was signiﬁcant elevation of CK-MB
level after PCI (Pre-procedural VS Post-procedural: 19.1  6.7 VS 52.46  9.4 mg/L,
p < 0.01). The mean rise of CK-MB level was higher in group II than group I
(33.0611.62U/L vs. 11.529.60 U/L). The ﬁndings were statistically signiﬁcant
between the study groups (p>0.05). Also there was a positive linear correlation be-
tween preprocediral hsCRP level and rise of CKMB (r¼0.22) following procedure and
it was statistically signiﬁcant (p<0.05). Multivariate logistic regression analysis done
among traditional predictors of PCI outcome advanced age (>50 years), female
gender, diabetes mellitus, BMI, hypertension, smoking, dylipidaemia, Type C lesion,
multiple stents, post dilatation and hsCRP. After removing the effects of the all other
variables, hs- CRP was independent predictors of periprocedural myocardial injury
during PCI, assessed by CK-MB elevation with OR 1.57 and p¼0.001.
Conclusion: The inﬂammatory activity, as represented by hs-CRP level, is associated
with procedure related microvascular injury as assessed by CK-MB elevation after
PCI. Measurement of hs-CRP levels could provide a rationale for risk stratiﬁcation
before coronary intervention and may be a useful tool to target aggressive anti-
aggregatory or anti-inﬂammatory therapy to patients that are exposed to the highest
risk for ischemic complications. As distal microembolization is a determinant of short
and long term mortality after PCI, speciﬁc strategies may be developed to minimize
myocardial injury in subjects with elevated hs-CRP level.
TCTAP A-199
Interaction Between Renin-angiotensin-aldosterone System Genes and Serum
Uric Acid on Blood Pressure
Chen Xin
Shanghai Sixth People’s hospital, Shanghai, China
Background: Hemodynamic changes in central aorta were independently associated
with target organ damage and cardiovascular diseases. Central blood pressure (BP)
may be more predictive than brachial BP. Understanding the interaction betweenJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POSTgenetic and environmental factors contributing to BP is an important issue in view of
the relation of hypertension with outcome. Genetic variation of renin-angiotensin-
aldosterone system (RAAS) genes is closely related to the susceptibility in hyper-
tension, and plays an important role in the changing of artery structure and function in
hypertensives. Moreover, because the pathophysiological role of central aortic and
brachial BP is different, genetic variations maybe have different effects on the regu-
lation of central and brachial BP. Using the standardized genetic epidemiological
methods in the general population, we studied the association of two single nucleotide
polymorphisms (SNPs) in RAAS genes including angiotensin II type 2 receptor
(AT2R, G1675A polymorphism), angiotensinogen (AGT, C-532T polymorphism)
with central and brachial BP and hypertension. We also studied the interaction be-
tween genes and environmental factors, in relation to central BP, brachial BP and
hypertension.
Methods: In 1293 residents of Zhejiang province, we conducted a questionnaire
survey, collected blood, estimated central blood pressure using the SphygmoCor de-
vice and genotyped two SNPs in candidate RAAS genes with polymerase chain re-
action-restriction fragment length polymorphism (PCR-RFLP) method and Taqman
probe method. SAS 9.1 software was used for statistical analysis.
Results: The 1293 participants included 308 (23.8%) hypertensive patients, of whom
106 (34.4%) were taking antihypertensive medication. For AGT C-532T poly-
morphism, CT and TT compared with CC had lower central pulse pressure (PP)
(P¼0.048) in all subjects and lower central SBP (P¼0.03) and PP (P¼0.02) in men.
Each T allele was associated with a lower central PP by 2.5mmHg. We found a
signiﬁcant interaction between AGT C-532T polymorphism and AT2R G1675A
polymorphism in relation to central SBP (Pint¼0.05). With the increase of the AGT
C-532T T allele, the A allele carriers of the AT2R G1675A polymorphism had a lower
central SBP (P¼0.05). We also found a signiﬁcant interaction between the AGT
C-532T polymorphism and serum uric acid in relation to central BP (Pint0.03).
Compared with AGT C-532T CC subjects central BP was signiﬁcantly lower in
T allele carriers with a concentration of serum uric acid between 264mmol/l and
319mmol/l (P0.04).
Conclusion: First, both in single gene analysis and analyses involving gene-gene,
gene-environment interactions, the T allele carriers of AGT C-532T polymorphism
(except women) showed a lower central SBP and PP. AGT C-532T polymorphism
may be associated with hypertension and arterial stiffness. Second, the interaction
between AGT C-532T polymorphism and AT2R G1675A polymorphism inﬂuenced
central SBP. With the increase of the AGT C-532T T allele, the A allele carriers of the
AT2R G1675A polymorphism had a lower central SBP compared with GG homo-
zygotes. The AT2R G1675A polymorphism may be involved in the blood pressure
regulation. Genetic variants of RAAS might interact with environmental factors in the
regulation of central BP, pathogenesis of hypertension and arterial stiffness.
TCTAP A-200
The Diffuse and Multi-vessel Coronary Artery Spasm Increase the Incidence of
Recurrent Chest Pain During 3-year Clinical Follow up
Sang-Ho Park1, Seung-Woon Rha2, Won-Yong Shin1, Dong-Kyu Jin1,
Byoung Geol Choi2, Se Yeon Choi2, Yoonjee Park2,
Akkala Raghavender Goud Hu Li2, Sunki Lee2, Ji Bak Kim2, Sung Il Im2, Jin Oh Na2,
Cheol Ung Choi2, Hong Euy Lim Lim2, Jin Won Kim2, Eung Ju Kim2,
Chang Gyu Park2, Hong Seog Seo2, Dong Joo Oh2
1Soonchunhyang University Cheonan Hospital, Cheonan, Korea (Republic of),
2Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: There are limited data how whether there are differences in clinical
outcomes according to spasm extent (focal versus diffuse) and spasm type (single
versus multi-vessel).
Methods: A total 2812 patients (pts) underwent coronary angiography with acetyl-
choline (Ach) provocation test from Nov 2004 to Oct 2010 from prospective spasm
registry were enrolled. The pts were categorized into three groups; negative spasm test
group (n¼1178), other positive group (n¼1098), diffuse and multivessel spasm group
(n¼536). The deﬁnition of diffuse spasm was deﬁned as longer than 30mm in length
of signiﬁcant spasm area. Other positive spasm group consisted of total positive Ach
provocation test groups except diffuse and multi-vessel spasm group. Cumulative
clinical outcomes up to 3 years were compared among the 3 groups.
Results: In proportional hazard Cox-regression analysis adjusted by co-variates such
as age, gender, current smoking, current alcoholics, myocardial bridge, HDL
cholesterol, hypertension, diabetes, and dyslipidemia, diffuse and multivessel spasm
group had the higher incidence of recurrent chest pain requiring repeat coronary
angiography during 3-year follow-up, compared to other positive spasm group (HR,
0.634; 95% CI, 0.431-0.931; p-value, 0.020) and negative spasm group (HR, 0.505;
95% CI, 0.336-0.758; p-value, <0.001). However, there was no difference between
other positive spasm group and negative spasm group (Figure).
Conclusion: The pts with diffuse and multivessel spasm was associated with higher
incidence of adverse clinical outcomes such as recurrent chest during 3-year follow-up
period.ER/Other (Unclassiﬁed) S57
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Impact of Simvastatin on Development of New-onset Diabetes Mellitus in Asian
Population: Three-year Clinical Follow up Results
Yoonjee Park, Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Cheol Ung Choi,
Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo,
Dong Joo Oh
Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: Although statin therapy is beneﬁcial for vascular diseases, the rela-
tionship between speciﬁc statin therapy and incidence of new-onset diabetes mellitus
(DM)remains uncertain. We evaluated the impact of Simvastatin therapyon the
development of new-onset DM from3-year clinicalfollow up datain a series of Asian
population.
Methods: A total of 3,436 consecutive patients who did not have DM were enrolled.
New-onset DMwas deﬁned as having a fasting blood glucose 126mg/dLor HbA1c
6.5%. Baseline characteristics between the Simvastatin and the control group were
propensity score matched (PSM, C-statics¼0.808). Three-year cumulative incidence
of new-onset DM was compared between the two groups.
Results: At baseline, patients in the Simvastatin group showed higher prevalence
ofelderly, male gender,dyslipidemia, coronary artery disease, smoking and alcoholic
history, and higher levels of HbA1c, fasting glucose, triglyceride, ﬁbrinogen,
and ALP. Three-year clinical follow up results showed a higher incidenceof
new-onset DM in the Simvastatin group (3.8% vs. 2%, p¼0.017). Following PSM
(C-statics¼0.808), the 2 groups were well balanced except for higher levels of
ﬁbrinogen, ALT, and ALP in the Simvastatin group. After adjustment, there was no
difference in the incidence of new-onset DMbetween the 2 groups up to 3years
(Figure).
Conclusion: In our study, the relationship between the use of Simvastatin and the
incidence of new-onset DM remains unclear. Long-term follow up with a larger study
population will be necessary for further information.S58 JACC Vol 63/12/Suppl S jTCTAP A-202
Is Acetyltransferase Activity an Indicator of BMS Condition in the Follow-up of
Coronary Stenting
David G. Iosseliani, Irina E. Kuznetsova
City Center of Interv. Cardioangiology, Moscow, Russian Federation
Background: In-stent stenosis remains one of the most thrilling problems of inter-
ventional cardiology, and the search of the ways of its solution includes the study of
causes andmechanisms of neointimal hyperproliferation. For this reason the study of the
impact of N-acetylation phenotype on the process of restenosis seems very interesting.
Methods: Retrospective study included 100 male patients aged 56,8  6,1 years on
the average, who received 116 coronary BMS for chronic CHD from December 2003
to January 2007. The patients have been selected for the study after control coronary
angiography performed in 7,2  2,2 months after PCI. The main inclusion criterion
was the presence of in-stent stenosis (Group 1, n¼50) and good mid-term results
(Group 2, control, n¼50) in the absence of known clinical and angiographic risk
factors for restenosis development. Baseline angiographic data of patients and im-
mediate results of PCI were evaluated by two independent experts. The standard
Sulphadimine was used as the test-agent. After single peroral intake of 500 mg of
Sulphadimine, the urine has been collected for 6 hours, and than the ratio of pro-
metabolized (N-acetyl-sulphadimine) and non-metabolized sulphadimine in urine was
determined with the help of high-effective liquid chromatography.
Results: Among the studied patients, there were 38% slow acetylators and 62% fast
acetylators. The analysis of the distribution of acetylation phenotype on groups 1 and
2 revealed high statistically signiﬁcant prevalence of fast acetylators among patients
with in-stent stenosis in the mid-term after PCI, P¼0,0006.
Conclusion: We revealed reliable direct correlation between the velocity of acetyla-
tion processes and the degree of in-stent stenosis after coronary stenting with BMS in
patients with chronic coronary heart disease.
TCTAP A-203
The “4S” Law for the Management of Iatrogenic Aortocoronary Dissection:
Clinical Results and Importance of Immediate Bail-out Stenting
Shao-Ping Nie, Edmundo Patricio Lopes Lao, Xiao Wang, Yan Qiao,
Chang-Sheng Ma
Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Background: Iatrogenic aortocoronary dissection is a rare but potentially disastrous
complication of percutaneous coronary intervention (PCI). However, there is a paucity
of data on the optimal initial management of this complication.The aim of this study
was to depict the characteristics and causes of iatrogenic aortocoronary dissection and
to elucidate the importance of a new strategy based on immediate bail-out stenting.
Methods: We collected 18 cases of iatrogenic aortocoronary dissection during PCI in
8 cardiac catheterization centers between 2005 and 2013, which were managed by a
single senior operator. A “4S” law based on immediate bail-out stenting performed
within 15 min was the initial strategy in most cases. The characteristics, treatment, and
in-hospital outcomes of the patients were evaluated.
Results: According to the NHLBI classiﬁcation, 15 patients (83.3%) had extensive
dissection (Type D to F) with acute closure (Type F) in 4 patients. In 3 patients
(16.7%), the dissections were diagnosed during coronary angiography, and in 15
patients (83.3%), during PCI. From the 18 patients, 16 patients (88.9%) underwent
bail-out stent implantation, with technical success in 14 patients. Among them, 13
patients followed the “4S” law, with 7.7  3.2 min from onset of dissection to
completion of bail-out stenting, and the procedural success rate was 100% with no
deaths. Two patients died due to time delay (stenting > 15min) and the third one died
due to hemodynamic collapse because the guidewire failed to cross the true lumen.
Conclusion: This study indicated that the “4S” law based on immediate bail-out
stenting is a feasible and efﬁcient strategy for the management of iatrogenic aorto-
coronary dissection.
TCTAP A-204
Abdominal Adiposity Measured with Dual Bioelectrical Impedance Analysis of
Hospitalized Patients in the Cardiology Ward
Kenji Sadamatsu, Kaoru Takegami, Taku Matsuura, Arihide Okahara,
Takaharu Shirahama, Daigo Mine, Yasuaki Koga, Yasutsugu Nagamoto,
Keiki Yoshida
Saga-ken Medical Centre Koseikan, Saga, Japan
Background: Obesity is a well-known risk factor of cardiovascular disease. However,
several reports demonstrated “obesity paradox”, while central obesity was associated
with the highest risk of mortality, which suggests the signiﬁcance of visceral fat
measurement. Recently, a novel system with dual bioelectrical impedance analysis
(HDS-2000, Omron healthcare, Kyoto) was developed. This technique does not need
radiation exposure and the measurements were validated to have a good correlation
with computed tomography.
Methods: A total of consecutive 60 patients (69.3  10.6 years old, male 80%)
admitted to the department of cardiology were measured their visceral fat areas with
dual bioelectrical impedance analysis. Control group included 23 healthy volunteers
(31.5  8.3 years old, male 57%).
Results: The values of body mass index (24.0  4.6 vs 21.6  2.6, p¼0.03) and
visceral fat area (82.0  51.6 vs 46.1  15.7 cm2, p<0.01) in the hospitalized patientsApril 22–25, 2014 j TCTAP Abstracts/POSTER/Other (Unclassiﬁed)
